The part that surprises me is the huge discussion on this! does this piece of PR really matter for MNTA investor?
Why do people here care about what MNTA is trading(does it really matter if it trades at $15 or $20?)?
What people should be focused are
1. What happens to Teva's Lovenox ANDA and if it does get approved, would MNTA's patents be strong enough to protect them 2. What happens in the Copaxone Patent trial 3. When would FDA actually approve Copaxone ANDA 4. How would the Oral MS drugs affect Copaxone and some of the key trials on Oral drugs may tell some tale 5. When would MNTA actually provide some concrete details to the market on the FOB pipeline with some sorta timelines 6. Of course, in the long run, FOB launches(2015-2016) themselves
Market Data 
Markets 
AI
